Unknown

Dataset Information

Fibrinogen concentrate for bleeding in patients with congenital fibrinogen deficiency: Observational study of efficacy and safety for prophylaxis and treatment.


ABSTRACT:

Background

Congenital fibrinogen deficiency (CFD) is a rare bleeding disorder characterized by reduced levels (afibrinogenemia, hypofibrinogenemia) or dysfunctional fibrinogen (dysfibrinogenemia), for which fibrinogen supplementation is the mainstay treatment.

Objectives

To assess the efficacy and safety of human fibrinogen concentrate (FCH) in patients with CFD.

Methods

This was a multicenter, noninterventional, retrospective cohort study with a 12-month prospective follow-up period in the United States and Canada. Individuals with CFD who received FCH for the treatment of bleeding, perioperative hemostasis, or prophylaxis were included. Data were collected retrospectively from medical records and every 3 months during the prospective period. Hemostatic efficacy was

SUBMITTER: Lasky J 

PROVIDER: S-EPMC7695557 | biostudies-literature | 2020 Nov

REPOSITORIES: biostudies-literature